BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19937137)

  • 1. miR-372 regulates cell cycle and apoptosis of ags human gastric cancer cell line through direct regulation of LATS2.
    Cho WJ; Shin JM; Kim JS; Lee MR; Hong KS; Lee JH; Koo KH; Park JW; Kim KS
    Mol Cells; 2009 Dec; 28(6):521-7. PubMed ID: 19937137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
    Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
    Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINC01088 regulates the miR-95/LATS2 pathway through the ceRNA mechanism to inhibit the growth, invasion and migration of gastric cancer cells.
    Wen Z; Li Y; Tan B; Chen Z; Zhao Q; Tan M; Zhao Y; Xia Y; FanΔ L
    Int J Immunopathol Pharmacol; 2022; 36():3946320221108271. PubMed ID: 35728587
    [No Abstract]   [Full Text] [Related]  

  • 5. MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer.
    Lee KH; Goan YG; Hsiao M; Lee CH; Jian SH; Lin JT; Chen YL; Lu PJ
    Exp Cell Res; 2009 Sep; 315(15):2529-38. PubMed ID: 19501585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-302b-3p Suppresses Cell Proliferation Through AKT Pathway by Targeting IGF-1R in Human Gastric Cancer.
    Guo B; Zhao Z; Wang Z; Li Q; Wang X; Wang W; Song T; Huang C
    Cell Physiol Biochem; 2017; 42(4):1701-1711. PubMed ID: 28743112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-92 overexpression suppresses immune cell function in ovarian cancer via LATS2/YAP1/PD-L1 pathway.
    Feng S; Sun H; Zhu W
    Clin Transl Oncol; 2021 Mar; 23(3):450-458. PubMed ID: 32654106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-107 and miR-25 simultaneously target LATS2 and regulate proliferation and invasion of gastric adenocarcinoma (GAC) cells.
    Zhang M; Wang X; Li W; Cui Y
    Biochem Biophys Res Commun; 2015 May; 460(3):806-12. PubMed ID: 25824045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta.
    Tsukamoto Y; Nakada C; Noguchi T; Tanigawa M; Nguyen LT; Uchida T; Hijiya N; Matsuura K; Fujioka T; Seto M; Moriyama M
    Cancer Res; 2010 Mar; 70(6):2339-49. PubMed ID: 20215506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA-25 Inhibits Cell Apoptosis of Human Gastric Adenocarcinoma Cell Line AGS via Regulating CCNE1 and MYC.
    Zhang Y; Peng Z; Zhao Y; Chen L
    Med Sci Monit; 2016 Apr; 22():1415-20. PubMed ID: 27120728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Hippo Kinase LATS2 Controls Helicobacter pylori-Induced Epithelial-Mesenchymal Transition and Intestinal Metaplasia in Gastric Mucosa.
    Molina-Castro SE; Tiffon C; Giraud J; Boeuf H; Sifre E; Giese A; Belleannée G; Lehours P; Bessède E; Mégraud F; Dubus P; Staedel C; Varon C
    Cell Mol Gastroenterol Hepatol; 2020; 9(2):257-276. PubMed ID: 31669263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-195 regulates cell apoptosis of human hepatocellular carcinoma cells by targeting LATS2.
    Yang X; Yu J; Yin J; Xiang Q; Tang H; Lei X
    Pharmazie; 2012 Jul; 67(7):645-51. PubMed ID: 22888524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long non-coding RNA H19-derived miR-675 modulates human gastric cancer cell proliferation by targeting tumor suppressor RUNX1.
    Zhuang M; Gao W; Xu J; Wang P; Shu Y
    Biochem Biophys Res Commun; 2014 Jun; 448(3):315-22. PubMed ID: 24388988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mir-629 Repressed LATS2 Expression and Promoted the Proliferation of Prostate Cancer Cells.
    Li Y; Zeng S; Cao L
    Horm Metab Res; 2023 Aug; 55(8):573-579. PubMed ID: 36990459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoliquiritigenin suppresses the proliferation and induced apoptosis via miR-32/LATS2/Wnt in nasopharyngeal carcinoma.
    Wang TT; Chen ZZ; Xie P; Zhang WJ; Du MY; Liu YT; Zhu HY; Guo YS
    Eur J Pharmacol; 2019 Aug; 856():172352. PubMed ID: 31004603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The circSNX14 functions as a tumor suppressor via the miR-562/ LATS2 pathway in hepatocellular carcinoma cells.
    Wu Y; Yang Y; Yi X; Song L
    J Mol Histol; 2023 Dec; 54(6):593-607. PubMed ID: 37861952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-206: Effective Inhibition of Gastric Cancer Progression through the c-Met Pathway.
    Zheng Z; Yan D; Chen X; Huang H; Chen K; Li G; Zhou L; Zheng D; Tu L; Dong XD
    PLoS One; 2015; 10(7):e0128751. PubMed ID: 26186594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of microRNA-224-3p Hampers Retinoblastoma Progression via Activation of the Hippo-YAP Signaling Pathway by Increasing LATS2.
    Song L; Huang Y; Zhang X; Han S; Hou M; Li H
    Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):32. PubMed ID: 32186675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor suppressor miR-24 restrains gastric cancer progression by downregulating RegIV.
    Duan Y; Hu L; Liu B; Yu B; Li J; Yan M; Yu Y; Li C; Su L; Zhu Z; Xiang M; Liu B; Yang Q
    Mol Cancer; 2014 May; 13():127. PubMed ID: 24886316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway.
    Wu T; Hu H; Zhang T; Jiang L; Li X; Liu S; Zheng C; Yan G; Chen W; Ning Y; Li Y; Lu Z
    Oxid Med Cell Longev; 2019; 2019():9719723. PubMed ID: 31316723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.